Literature DB >> 30654040

Cytotoxic, genotoxic, and oxidative stress-inducing effect of an l-amino acid oxidase isolated from Bothrops jararacussu venom in a co-culture model of HepG2 and HUVEC cells.

A R T Machado1, A F Aissa1, D L Ribeiro2, T R Costa1, R S Ferreira3, S V Sampaio1, L M G Antunes4.   

Abstract

Hepatocellular carcinoma incidence rates have increased worldwide, which encouraged the development of new chemotherapeutic drugs. l-Amino acid oxidases from snake venoms are cytotoxic towards human tumor cells in in vitro monoculture systems, which do not simulate the tumor microenvironment. We examined the antitumor potential of BjussuLAAO-II, an l-amino acid oxidase from Bothrops jararacussu venom, in hepatocarcinoma cells (HepG2) in monoculture and co-culture with human umbilical vein endothelial cells (HUVEC) in vitro. All the concentrations tested (0.25-5.00 μg/mL) were cytotoxic (MTT and clonogenic survival assays) towards HepG2 and HUVEC cells in monoculture, and increased oxidative stress by 2',7'-dichlorofluorescin diacetate fluorescence assay. Only 1.00 and 5.00 μg/mL exerted these effects in HepG2 cells co-cultured with HUVEC cells, and were genotoxic (comet assay) to HUVEC cells in monoculture. BjussuLAAO-II at 5.00 μg/mL induced DNA, but not chromosomal damage (micronucleus assay) in HepG2 cells in mono- and co-culture. The cytotoxicity and genotoxicity was more pronounced in monoculture, indicating that the tumor microenvironment influences the cellular response. BjussuLAAO-II caused cell death and DNA damage in HepG2 cells in vitro by inducing oxidative stress. Therefore, BjussuLAAO-II is a promising molecule for the development of new antitumor drugs. Published by Elsevier B.V.

Entities:  

Keywords:  Micronucleus; Snake venom; Tumor microenvironment

Mesh:

Substances:

Year:  2019        PMID: 30654040     DOI: 10.1016/j.ijbiomac.2019.01.059

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  6 in total

1.  P-I metalloproteinases and L-amino acid oxidases from Bothrops species inhibit angiogenesis.

Authors:  Shreesha K Bhat; Manjunath B Joshi; Sampara Vasishta; Rajesh N Jagadale; Setlur G Biligiri; Monika A Coronado; Raghuvir K Arni; Kapaettu Satyamoorthy
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2021-08-18

Review 2.  Antimicrobial properties of L-amino acid oxidase: biochemical features and biomedical applications.

Authors:  Kosuke Kasai; Manabu Nakano; Masami Ohishi; Toshiya Nakamura; Tomisato Miura
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-09       Impact factor: 4.813

3.  Bothrops moojeni L-amino acid oxidase induces apoptosis and epigenetic modulation on Bcr-Abl+ cells.

Authors:  Sandra Mara Burin; Maira da Costa Cacemiro; Juçara Gastaldi Cominal; Rone Aparecido De Grandis; Ana Rita Thomazela Machado; Flavia Sacilotto Donaires; Adelia Cristina Oliveira Cintra; Luciana Ambrosio; Lusânia Maria Greggi Antunes; Suely Vilela Sampaio; Fabíola Attié de Castro
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-12-14

4.  A New Approach to Inhibiting Triple-Negative Breast Cancer: In Vitro, Ex Vivo and In Vivo Antiangiogenic Effect of BthTx-II, a PLA2-Asp-49 from Bothrops jararacussu Venom.

Authors:  Fernanda Van Petten de Vasconcelos Azevedo; Daiana Silva Lopes; Mariana Alves Pereira Zóia; Lucas Ian Veloso Correia; Natieli Saito; Belchiolina Beatriz Fonseca; Lorena Polloni; Samuel Cota Teixeira; Luiz Ricardo Goulart; Veridiana de Melo Rodrigues Ávila
Journal:  Biomolecules       Date:  2022-02-04

Review 5.  Structure-Function Studies and Mechanism of Action of Snake Venom L-Amino Acid Oxidases.

Authors:  Anwar Ullah
Journal:  Front Pharmacol       Date:  2020-02-25       Impact factor: 5.810

6.  Modeling Endothelialized Hepatic Tumor Microtissues for Drug Screening.

Authors:  Ying Wang; Ranjith Kumar Kankala; Jianting Zhang; Liuzhi Hao; Kai Zhu; Shibin Wang; Yu Shrike Zhang; Aizheng Chen
Journal:  Adv Sci (Weinh)       Date:  2020-09-21       Impact factor: 16.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.